Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem

Published:2021-02 Issue: Volume:324 Page:255-260
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Fresse Audrey,Viard Delphine,Romani Serena,Gérard Alexandre,Lepelley Marion,Rocher Fanny,Salem Joe-Elie,Drici Milou-Daniel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture;de Wilde;Antimicrob. Agents Chemother.,2014

2. Why are Lopinavir and ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms;Nutho;Biochemistry.,2020

3. Lopinavir/ritonavir in the treatment of HIV-1 infection: a review;Chandwani;Ther. Clin. Risk Manag.,2008

4. Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection;Chaubey;Sex. Health,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An artificial intelligence algorithm for co‐clustering to help in pharmacovigilance before and during the COVID‐19 pandemic;British Journal of Clinical Pharmacology;2024-02-08

2. Drug-induced cardiac toxicity and adverse drug reactions, a narrative review;Therapies;2023-10

3. COVID-19 and atrial fibrillation: Intercepting lines;Frontiers in Cardiovascular Medicine;2023-01-23

4. Possible nirmatrelvir/ritonavir-induced bradycardia in a patient with asymptomatic COVID-19;SAGE Open Medical Case Reports;2023-01

5. Hydroxychloroquine Attenuates hERG Channel by Promoting the Membrane Channel Degradation: Computational Simulation and Experimental Evidence for QT-Interval Prolongation with Hydroxychloroquine Treatment;Cardiology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3